158 related articles for article (PubMed ID: 34616614)
1. DNMT family induces down-regulation of NDRG1
Chang X; Ma J; Xue X; Wang G; Yan T; Su L; Han X; Zhou H; Hou L
PeerJ; 2021; 9():e12146. PubMed ID: 34616614
[TBL] [Abstract][Full Text] [Related]
2. NDRG1 was downregulated and worked as favorable biomarker in the development of gastric cancer.
Xiao XJ; Zheng HC
Transl Cancer Res; 2020 Jan; 9(1):210-221. PubMed ID: 35117175
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of the expression of DNA methyltransferase proteins in gastric cancer.
Yang J; Wei X; Wu Q; Xu Z; Gu D; Jin Y; Shen Y; Huang H; Fan H; Chen J
Mol Med Rep; 2011; 4(6):1139-43. PubMed ID: 21887466
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance and prognostic value of DNA methyltransferase 1, 3a, and 3b expressions in sporadic epithelial ovarian cancer.
Bai X; Song Z; Fu Y; Yu Z; Zhao L; Zhao H; Yao W; Huang D; Mi X; Wang E; Zheng Z; Wei M
PLoS One; 2012; 7(6):e40024. PubMed ID: 22768205
[TBL] [Abstract][Full Text] [Related]
5. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
Oh BK; Kim H; Park HJ; Shim YH; Choi J; Park C; Park YN
Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390
[TBL] [Abstract][Full Text] [Related]
6. Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells.
Agarwal S; Amin KS; Jagadeesh S; Baishay G; Rao PG; Barua NC; Bhattacharya S; Banerjee PP
Mol Cancer; 2013 Aug; 12(1):99. PubMed ID: 24001151
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E
Wong CC; Kang W; Xu J; Qian Y; Luk STY; Chen H; Li W; Zhao L; Zhang X; Chiu PW; Ng EK; Yu J
Theranostics; 2019; 9(21):6256-6268. PubMed ID: 31534549
[No Abstract] [Full Text] [Related]
8. Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation.
Chang HC; Cho CY; Hung WC
Cancer Res; 2006 Sep; 66(17):8413-20. PubMed ID: 16951151
[TBL] [Abstract][Full Text] [Related]
9. Association of NDRG1 gene promoter methylation with reduced NDRG1 expression in gastric cancer cells and tissue specimens.
Chang X; Zhang S; Ma J; Li Z; Zhi Y; Chen J; Lu Y; Dai D
Cell Biochem Biophys; 2013 May; 66(1):93-101. PubMed ID: 23099645
[TBL] [Abstract][Full Text] [Related]
10. Aberrant NDRG1 methylation associated with its decreased expression and clinicopathological significance in breast cancer.
Han LL; Hou L; Zhou MJ; Ma ZL; Lin DL; Wu L; Ge YL
J Biomed Sci; 2013 Jul; 20(1):52. PubMed ID: 23899187
[TBL] [Abstract][Full Text] [Related]
11. Methylation of miR-124a-1, miR-124a-2, and miR-124a-3 genes correlates with aggressive and advanced breast cancer disease.
Ben Gacem R; Ben Abdelkrim O; Ziadi S; Ben Dhiab M; Trimeche M
Tumour Biol; 2014 May; 35(5):4047-56. PubMed ID: 24375250
[TBL] [Abstract][Full Text] [Related]
12. Aberrant promotor methylation in MDS hematopoietic cells during in vitro lineage specific differentiation is differently associated with DNMT isoforms.
Hopfer O; Komor M; Koehler IS; Freitag C; Schulze M; Hoelzer D; Thiel E; Hofmann WK
Leuk Res; 2009 Mar; 33(3):434-42. PubMed ID: 18829110
[TBL] [Abstract][Full Text] [Related]
13. DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.
Roll JD; Rivenbark AG; Jones WD; Coleman WB
Mol Cancer; 2008 Jan; 7():15. PubMed ID: 18221536
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase.
Benbrahim-Tallaa L; Waterland RA; Dill AL; Webber MM; Waalkes MP
Environ Health Perspect; 2007 Oct; 115(10):1454-9. PubMed ID: 17938735
[TBL] [Abstract][Full Text] [Related]
15. E3 ubiquitin ligase RNF180 prevents excessive PCDH10 methylation to suppress the proliferation and metastasis of gastric cancer cells by promoting ubiquitination of DNMT1.
Zhang N; Gao X; Yuan Q; Fu X; Wang P; Cai F; Liu H; Zhang J; Liang H; Nie Y; Deng J
Clin Epigenetics; 2023 May; 15(1):77. PubMed ID: 37147733
[TBL] [Abstract][Full Text] [Related]
16. The expression and clinical significance of DNA methyltransferase proteins in human gastric cancer.
Ding WJ; Fang JY; Chen XY; Peng YS
Dig Dis Sci; 2008 Aug; 53(8):2083-9. PubMed ID: 18253830
[TBL] [Abstract][Full Text] [Related]
17. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers.
Xiong Y; Dowdy SC; Xue A; Shujuan J; Eberhardt NL; Podratz KC; Jiang SW
Gynecol Oncol; 2005 Mar; 96(3):601-9. PubMed ID: 15721400
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the prognostic values of the
Yu C; Hao X; Zhang S; Hu W; Li J; Sun J; Zheng M
Therap Adv Gastroenterol; 2019; 12():1756284819858507. PubMed ID: 31384305
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells.
Ahluwalia A; Hurteau JA; Bigsby RM; Nephew KP
Gynecol Oncol; 2001 Aug; 82(2):299-304. PubMed ID: 11531283
[TBL] [Abstract][Full Text] [Related]
20. Deregulation between miR-29b/c and DNMT3A is associated with epigenetic silencing of the CDH1 gene, affecting cell migration and invasion in gastric cancer.
Cui H; Wang L; Gong P; Zhao C; Zhang S; Zhang K; Zhou R; Zhao Z; Fan H
PLoS One; 2015; 10(4):e0123926. PubMed ID: 25874772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
